NEW YORK STATE COMMON RETIREMENT FUND - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 126 filers reported holding ANAPTYSBIO INC in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q3 2023$143
-11.2%
7,963
+0.5%
0.00%
Q2 2023$161
-41.5%
7,921
-37.3%
0.00%
Q1 2023$275
-48.2%
12,642
-26.3%
0.00%
-100.0%
Q4 2022$531
-99.8%
17,142
+25.6%
0.00%0.0%
Q3 2022$348,000
+26.1%
13,653
+0.3%
0.00%
Q2 2022$276,000
-18.3%
13,609
-0.3%
0.00%
Q1 2022$338,000
-24.2%
13,647
+6.4%
0.00%
Q4 2021$446,000
+27.8%
12,828
-0.3%
0.00%
Q3 2021$349,000
-19.6%
12,861
-23.2%
0.00%
Q2 2021$434,000
-3.1%
16,738
-19.4%
0.00%
Q1 2021$448,000
-3.0%
20,766
-3.3%
0.00%
-100.0%
Q4 2020$462,000
+45.7%
21,4660.0%0.00%
Q3 2020$317,000
-34.0%
21,4660.0%0.00%
-100.0%
Q2 2020$480,000
+58.4%
21,4660.0%0.00%
Q1 2020$303,000
-26.3%
21,466
-15.2%
0.00%
Q4 2019$411,000
-53.6%
25,3000.0%0.00%
-100.0%
Q3 2019$885,000
-37.8%
25,300
+0.4%
0.00%
-50.0%
Q2 2019$1,422,000
-7.7%
25,200
+19.4%
0.00%0.0%
Q1 2019$1,541,000
+29.2%
21,100
+12.8%
0.00%0.0%
Q4 2018$1,193,000
-48.6%
18,700
-19.5%
0.00%
-33.3%
Q3 2018$2,319,000
+40.5%
23,2390.0%0.00%
+50.0%
Q2 2018$1,651,000
-27.4%
23,239
+6.4%
0.00%
-33.3%
Q1 2018$2,273,000
+61.4%
21,839
+56.2%
0.00%
+50.0%
Q4 2017$1,408,000
+374.1%
13,984
+64.5%
0.00%
Q3 2017$297,000
+76.8%
8,500
+21.4%
0.00%
Q2 2017$168,0007,0000.00%
Other shareholders
ANAPTYSBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,628,678$81,462,73111.84%
EcoR1 Capital, LLC 7,521,024$233,076,5347.09%
5AM Venture Management, LLC 357,733$11,086,1462.98%
Boxer Capital, LLC 1,300,000$40,287,0002.12%
Frazier Life Sciences Management, L.P. 899,700$27,881,7031.73%
Palo Alto Investors LP 431,024$13,357,4341.14%
Logos Global Management LP 250,000$7,747,5000.91%
BRAIDWELL LP 726,122$22,502,5210.75%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,161,826$36,004,9880.74%
Rock Springs Capital Management LP 576,600$17,868,8340.43%
View complete list of ANAPTYSBIO INC shareholders